Ny behandling mot smärta och feber vid reumatoid artrit och artros: De två första cyklooxygenas-2-hämmarna visar lovande resultat

Lakartidningen

Volumn 97, Issue 24, 2000, Pages 2942-2944

  Oliw, Ernst ^a   Wollheim, Frank A ^b  

^a UPPSALA UNIVERSITY   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CELECOXIB; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; ISOENZYME; LACTONE; MEMBRANE PROTEIN; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN SYNTHASE; PROSTAGLANDIN SYNTHASE INHIBITOR; PTGS2 PROTEIN, HUMAN; PYRAZOLE DERIVATIVE; ROFECOXIB; SULFONAMIDE; SULFONE;

CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; HUMAN; OSTEOARTHRITIS; RANDOMIZED CONTROLLED TRIAL; REVIEW; RHEUMATOID ARTHRITIS; TREATMENT OUTCOME;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTHRITIS, RHEUMATOID; CONTROLLED CLINICAL TRIALS; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; HUMANS; ISOENZYMES; LACTONES; MEMBRANE PROTEINS; OSTEOARTHRITIS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PYRAZOLES; RANDOMIZED CONTROLLED TRIALS; SULFONAMIDES; SULFONES; TREATMENT OUTCOME;

EID: 0034647177     PISSN: 00237205     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Marnett LJ, Kalgutkar AS. Cyclooxygenase 2 inhibitors: discovery, selectivity and the future. Trends Pharmacol Sci 1999; 20: 465-9.
2. Simon LS, Weaver AL, Graham DY, Kivitz AJ, Lipsky PE, Hubbard RC et al. Anti-inflammatory and upper gastro-intestinal effects of celecoxib in rheumatoid arthritis. A randomised controlled trial. JAMA 1999; 282: 1921-8.
3. Emery P, Zeidler H, Kvien T, Guslandi M, Naudin R, Stead H et al. Celecoxib versus diclofenac in long-term management of rheumatoid arthritis: randomised double-blind comparison. Lancet 1999; 354: 210-611.
4. Bensen WG, Fiechtner JJ, McMillen JI, Zhao WW, Yu SS, Woods EM et al. Treatment of osteoarthritis with celecoxib, a cyclooxygenase-2 inhibitor: A randomised controlled trial. Mayo Clin Proc 1999; 74: 1095-105.
5. Scott LJ, Lamb HM. Rofecoxib. Drugs 1999; 58: 499-505.
6. Laine L, Harper S, Simon T, Bath R, Johanson J, Schwartz H et al. A randomised trial comparing the effect of rofecoxib, a cyclooxygenase 2-specific inhibitor, with that of ibuprofen on the gastroduodenal mucosa of patients with osteoarthritis. Gastroenterology 1999; 117: 778-83.
7. Langman MJ, Jensen DM, Harper SE, Zhao PL, Quan H, Bolognese JA et al. Adverse upper gastrointestinal effects of rofecoxib compared with NSAIDs. JAMA 1999; 282: 1929-33.
8. Wollheim FA. New functions for Cox-2 in health and disease: report of the Third International Workshop on Cox-2. http://arthritis-research.com/26oct99/ar0101n01